Mr. Essig added, "We want to thank Jan for his leadership and contributions to Integra, many of which lay the groundwork for future success. His focus on growing our international business, integrating digital technology into our product pipeline, attracting top talent and building strong, capable teams will leave a lasting impact on Integra. In addition, Jan shaped our portfolio through the strategic acquisitions of Surgical Innovation Associates, the makers of Durasorb ®, and Acclarent. We also appreciate Jan's leadership in driving our operational and quality compliance strategic plans and his commitment to facilitating a smooth leadership transition."